• Department of Pulmonary and Critical Care Medicine, People’s Hospital of China Three Gorges University / the First Hospital of Yichang, Yichang, Hubei 443000, P. R. China;
NI Jixiang, Email: keamin77@163.com
Export PDF Favorites Scan Get Citation

Patients with coronavirus disease 2019 may have systemic symptoms of varying degrees. These symptoms are related to inflammatory response, massive release of pro-inflammatory cytokines and cytokine storm. In recent years, programmed necrosis, as a controllable type of necrosis, is considered to be an important factor that mediates inflammation. Recent studies have shown that programmed necrosis is involved in the inflammatory response and pulmonary fibrosis of coronavirus disease 2019. This article mainly reviews the mechanism of programmed necrosis, its participation in the occurrence and development of coronavirus disease 2019, and the research progress of programmed necrosis inhibitors in the treatment of coronavirus disease 2019, aiming to provide a certain basis for the diagnosis and treatment of coronavirus disease 2019.

Citation: XU Biao, NI Jixiang, YANG Yuting, LUO Gan, LI Xiaojuan. Research progress of programmed necrosis in coronavirus disease 2019. West China Medical Journal, 2022, 37(1): 22-26. doi: 10.7507/1002-0179.202104146 Copy

  • Previous Article

    Application of hospital-level and department-level supervision in coronavirus disease 2019 epidemic prevention and control
  • Next Article

    Relationship between abdominal fat distribution and pulmonary ventilation function